Funder
Sociedad Española de Cardiología
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference39 articles.
1. Alberti, K. G., Eckel, R. H., Grundy, S. M., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation., 120(16), 1640–1645.
2. (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA., 285(19), 2486–2497.
3. Alberti, K. G., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine: a Journal of the British Diabetic Association., 15(7), 539–553.
4. Fernandez-Berges, D., Cabrera de Leon, A., Sanz, H., et al. (2012). Metabolic syndrome in Spain: Prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study. Revista Espanola de Cardiologia (English Edition), 65(3), 241–248.
5. Gami, A. S., Witt, B. J., Howard, D. E., et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. Journal of the American College of Cardiology, 49(4), 403–414.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献